Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
United States of America Ex Rel et al v. Davita, Inc. et al
Case Number:
1:07-cv-02509
Court:
Nature of Suit:
Judge:
Firms
- Bondurant Mixson
- Cook & Connelly
- Gibbs & Bruns
- Jones Day
- King & Spalding
- Krevolin & Horst
- Maloy Jenkins
- McDermott Will & Emery
- Reynolds Frizzell
- Wade Grunberg
- Weissmann Zucker
- Wilbanks & Gouinlock
Companies
Sectors & Industries:
-
May 04, 2015
DaVita To Pay Record $495M To Settle Kidney Drug FCA Suit
DaVita Inc. said Monday it set aside $495 million as part of a tentative deal to resolve a False Claims Act whistleblower suit for allegedly bilking taxpayers for reimbursement of intentionally overused dialysis drugs, which a plaintiff's attorney called the largest settlement for an FCA case brought without government intervention.
-
April 16, 2015
DaVita To Settle FCA Suit After Witness Coaching Inquiry
DaVita Inc. said Thursday it will settle a False Claims Act whistleblower suit accusing the company of bilking taxpayers by seeking reimbursement for intentionally overused dialysis drugs, nearly three months after a Georgia federal judge conducted a review to determine whether witnesses were coached into changing their testimony after discovery was reopened.
-
January 29, 2015
False DaVita Testimony Jeopardizing Privilege In FCA Suit
A Georgia federal judge has ordered the review of communications between defense lawyers and witnesses in a False Claims Act suit against DaVita Inc. for allegedly seeking reimbursement on intentionally overused dialysis drugs, after finding the witnesses may have been coached to change their testimony.
-
November 12, 2014
DaVita Hit With Sanction Request In Kidney Drug FCA Suit
Whistleblowers asked a Georgia federal judge on Tuesday to again sanction Davita Inc. for lying and failing to fully respond to discovery requests in a False Claims Act suit accusing the company of bilking taxpayers by seeking reimbursement for intentionally overused dialysis drugs.
-
August 15, 2014
Davita Calls Whistleblowers' FCA Kidney Drugs Suit Flawed
Davita Inc. urged a Georgia federal court on Thursday to toss a whistleblower suit alleging it bilked taxpayers by seeking reimbursement for intentionally overused or wasted dialysis drugs, saying its dosing practices were objectively reasonable and can't be used to hold it liable under the False Claims Act.
-
August 13, 2014
Dialysis Co. Faces Sanctions For False Testimony In FCA Suit
A Georgia federal judge granted a motion for sanctions Tuesday against DaVita Healthcare Partners Inc. in a False Claims Act suit accusing the company of bilking taxpayers by seeking reimbursement for intentionally overused dialysis drugs, finding DaVita had provided false information about a computer program used to determine dosage levels.
-
June 02, 2014
Ex-DaVita Staffers Fight To Keep FCA Suit Alive
Whistleblowers on Friday pressed a Georgia federal judge to preserve their False Claims Act suit accusing DaVita Inc. of bilking taxpayers by seeking reimbursement for intentionally overused dialysis drugs, saying there is still a clear dispute over whether Medicare prohibits paying for relatively wasteful practices.
-
May 07, 2013
Whistleblowers Say DaVita Abusing Doc Privilege In FCA Case
The relators in a False Claims Act suit accusing DaVita Inc. of creating waste to overbill Medicare told a Georgia federal court Monday that the dialysis service provider was abusing attorney-client privilege by labeling an excessive amount of communications as confidential.
-
April 26, 2012
Dialysis Co. Says Prior Deal Bars Some FCA Claims
Global dialysis firm Gambro Healthcare Inc. urged a judge on Tuesday to block portions of a False Claims Act case in which former employees accuse it of creating waste in order to overbill Medicare, saying the lawsuit is partly preempted by a past settlement.
-
March 02, 2012
DaVita Can't Escape FCA Suit Over Kidney Med Charges
A Georgia federal judge on Friday kept alive most of a False Claims Act suit brought by two former DaVita Inc. employees accusing the kidney care provider of fraudulently billing Medicare and other programs for the intentional waste of dialysis medications.